- Report
- June 2021
- 50 Pages
China
From €2510EUR$2,600USD£2,153GBP
- Report
- November 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- August 2022
Global
From €1052EUR$1,090USD£902GBP
- Report
- May 2019
- 46 Pages
Global
From €6752EUR$6,995USD£5,791GBP
- Report
- October 2021
- 80 Pages
Asia Pacific
From €1448EUR$1,500USD£1,242GBP
- Report
- October 2021
- 80 Pages
Middle East, Africa
From €1448EUR$1,500USD£1,242GBP
- Report
- October 2021
- 72 Pages
North America
From €1448EUR$1,500USD£1,242GBP
- Report
- October 2021
- 189 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- October 2021
- 79 Pages
Europe
From €1448EUR$1,500USD£1,242GBP
- Drug Pipelines
- November 2020
- 640 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Drug Pipelines
- June 2020
- 54 Pages
Global
From €3378EUR$3,500USD£2,898GBP
- Report
- January 2024
- 80 Pages
United Kingdom
From €2505EUR$2,595USD£2,149GBP
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2024
- 80 Pages
South Korea
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2024
- 80 Pages
Saudi Arabia
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2024
- 80 Pages
India
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2024
- 80 Pages
Germany
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2024
- 80 Pages
France
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2024
- 80 Pages
China
From €2505EUR$2,595USD£2,149GBP
- Drug Pipelines
- March 2023
- 136 Pages
Global
From €10612EUR$10,995USD£9,103GBP
The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat.
The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more